These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37025062)

  • 1. Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3.
    Rufino-Ramos D; Albuquerque PR; Leandro K; Carmona V; Martins IM; Fernandes R; Henriques C; Lobo D; Faro R; Perfeito R; Mendonça LS; Pereira D; Gomes CM; Nobre RJ; Pereira de Almeida L
    Mol Ther; 2023 May; 31(5):1275-1292. PubMed ID: 37025062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease.
    Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L
    Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
    Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
    Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the
    Lian M; Tan VJ; Taguchi R; Zhao M; Phang GP; Tan AS; Liu S; Lee CG; Chong SS
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machado Joseph-Disease Is Rare in the Peruvian Population.
    Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
    Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.
    Paulino R; Nóbrega C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.
    Nobre RJ; Lobo DD; Henriques C; Duarte SP; Lopes SM; Silva AC; Lopes MM; Mariet F; Schwarz LK; Baatje MS; Ferreira V; Vallès A; Pereira de Almeida L; Evers MM; Toonen LJA
    Nucleic Acid Ther; 2022 Jun; 32(3):194-205. PubMed ID: 34878314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.
    Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP
    PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of engineered exosome-based miR-25 and miR-181a treatment in spinocerebellar ataxia type 3 mice by silencing ATXN3.
    Tang Z; Hu S; Wu Z; He M
    Mol Med; 2023 Jul; 29(1):96. PubMed ID: 37438701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-25 and miR-181 Family Members Correlates with Reduced Expression of ATXN3 in Lymphocytes from SCA3 Patients.
    Krauss S; Nalavade R; Weber S; Carter K; Evert BO
    Microrna; 2019; 8(1):76-85. PubMed ID: 30147021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planning Future Clinical Trials for Machado-Joseph Disease.
    Saute JAM; Jardim LB
    Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease.
    Fardghassemi Y; Parker JA
    Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.
    Vasconcelos-Ferreira A; Carmo-Silva S; Codêsso JM; Silva P; Martinez ARM; França MC; Nóbrega C; Pereira de Almeida L
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12763. PubMed ID: 34432315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
    Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
    Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the calpain-generated toxic fragment of ataxin-3 protein provides new avenues for therapy of Machado-Joseph disease| Spinocerebellar ataxia type 3.
    Simões AT; Carmona V; Duarte-Neves J; Cunha-Santos J; Pereira de Almeida L
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12748. PubMed ID: 34273111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent therapeutic prospects for Machado-Joseph disease.
    Costa MDC
    Curr Opin Neurol; 2020 Aug; 33(4):519-526. PubMed ID: 32657894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
    Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
    Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
    Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
    Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson H
    Handb Clin Neurol; 2012; 103():437-49. PubMed ID: 21827905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.